Related Experiment Video
Updated: Dec 3, 2025
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
19.1K
Tuberculosis in Poland in 2018
1National Tuberculosis and Lung Diseases Research Institute, Department of Tuberculosis Epidemiology and Surveillance.
Przeglad Epidemiologiczny
|October 28, 2020
Summary
Tuberculosis incidence in Poland decreased in 2018 but remains higher than the EU/EEA average. Higher rates were seen in older adults and males, with fewer pediatric cases and substantial impact from migration or MDR-TB.
Area of Science:
- Epidemiology
- Public Health
- Infectious Diseases
Background:
- Tuberculosis (TB) remains a significant global health concern.
- Understanding national TB epidemiology is crucial for targeted interventions.
- Poland's TB data in 2018 provides a snapshot for comparison with EU/EEA trends.
Purpose of the Study:
- To evaluate the main features of tuberculosis (TB) epidemiology in Poland in 2018.
- To compare Poland's TB situation with that of EU/EEA countries.
- To analyze demographic and clinical characteristics of TB cases.
Main Methods:
- Analysis of national TB case-based data from the National TB Register for 2018.
- Inclusion of drug susceptibility testing, HIV co-infection, and mortality data.
- Comparison with European Centre for Disease Prevention and Control (ECDC) and WHO reports.
Main Results:
- Poland reported 5487 TB cases in 2018, with an incidence rate of 14.3 per 100,000 population.
- Incidence varied significantly by voivodeship and was higher in males (21.0/100,000) and older age groups (≥65 years: 21.3/100,000).
- Pulmonary TB constituted 95.2% of cases; MDR-TB was found in 1.3% of cases with known drug susceptibility testing (DST) results.
Conclusions:
- Tuberculosis incidence in Poland decreased in 2018 but exceeded the EU/EEA average.
- Higher incidence rates were observed in older age groups and males.
- Pediatric TB cases and the impact of migration were less significant compared to EU/EEA averages; MDR-TB was less common.
Keywords:
2018PolandTB casesTB cases of foreign originTB confirmed by cultureTB in children and adolescentsTB in prisonsTB incidenceTB mortalityTB/HIV co-infectiondrug susceptibility reportingextrapulmonary TBmulti-drug resistant TB (MDR-TB)new casespreviously treated casespulmonary TBthe National Tuberculosis Registertuberculosis (TB)
Related Concept Videos
01:29Pulmonary Tuberculosis I
574
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
574
01:28Pulmonary Tuberculosis V
349
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
349
01:28Pulmonary Tuberculosis II
1.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.0K
01:26Pulmonary Tuberculosis IV
309
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
309
01:31Pulmonary Tuberculosis III
669
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
669
01:17Other Pulmonary Disorders
1.4K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.4K